Skip to main content
  • 442 Accesses

Abstract

As the Edmond J. Safra Center for Ethics has developed its lens for studying institutional corruption, it has focused on the need for researchers to identify the “improper dependencies”—or, alternatively described, the “economies of influence”—that may have proven corrupting to the institution. In the previous chapter, we looked at how, with the publication of DSM-III, a potential conflict arose between the APA’s guild interests and its ethical obligations as a medical discipline. The APA had a guild interest in promoting its new disease model, and yet, at the same time, it had an ethical obligation to inform the public, in a thorough and balanced way, what research was revealing about the nature of psychiatric disorders and the drugs used to treat them. In this chapter, we begin our inquiry into the conduct of the APA and organized psychiatry since that seminal moment in 1980, and, as a first step, it is necessary to detail the rise and growth of “economies of influence” that may have shaped psychiatry’s behavior during the past 35 years. In this way, it is possible to see the financial influences that have been present during this period, and may have affected psychiatry’s conduct.

Dependence upon funders produces a subtle, understated, camouflaged bending to keep the funders happy … they become in the words of the X Files, “shape shifters” as they constantly adjust their views.

—Lawrence Lessig, 20131

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

  1. L. Lessig. “We the People, and the Republic We Must Reclaim.” TED talk, February 2013.

    Google Scholar 

  2. M. Sabshin. “Report of the medical director.” Am J Psychiatry 137 (1980): 1308–12.

    Article  Google Scholar 

  3. L. Havens. “Twentieth-century psychiatry.” Am J Psychiatry 138 (1981): 1279–87.

    Article  Google Scholar 

  4. M. Sabshin. “Report of the medical director.” Am J Psychiatry 138 (1981): 1418–21.

    Article  Google Scholar 

  5. W. Sorum. “Report of the speaker.” Am J Psychiatry 140 (1983): 1403–4.

    Article  Google Scholar 

  6. M. Sabshin. “Report of the medical director.” Am J Psychiatry 139 (1982): 1392–6.

    Article  Google Scholar 

  7. M. Sabshin. “Report of the medical director.” Am J Psychiatry 140 (1983): 1397–1403.

    Article  Google Scholar 

  8. M. Sabshin. “Report of the medical director.” Am J Psychiatry 143 (1986): 1342–6.

    Article  Google Scholar 

  9. S. Frazier. “Report of the secretary, summary of meetings of Board of Trustees, May 1983–1984.” Am J Psychiatry 141 (1984): 1314–21.

    Article  Google Scholar 

  10. M. Sabshin. “Report of the medical director.” Am J Psychiatry 142 (1985): 1243–6; and Sabshin, 1986, ibid.

    Article  Google Scholar 

  11. M. Sabshin. Changing American Psychiatry (Washington, DC: American Psychiatric Publishing, 2008): 78.

    Google Scholar 

  12. M. Sabshin. “Report of the medical director.” Am J Psychiatry, 147 (1990): 1411–17.

    Article  Google Scholar 

  13. E. Benedek. “Report of the secretary: summary of actions of the Board of Trustees, May 1986–May 1987.” Am J Psychiatry 144 (1987): 1381–8.

    Article  Google Scholar 

  14. M. Sabshin. “Report of the medical director.” Am J Psychiatry 144 (1987): 1390–3.

    Article  Google Scholar 

  15. M. Sabshin. “Report of the medical director.” Am J Psychiatry 149 (1992): 1434–44.

    Article  Google Scholar 

  16. M. Sabshin. “Report of the medical director.” Am J Psychiatry 150 (1993): 1591–601.

    Article  Google Scholar 

  17. M. Sabshin. “Report of the medical director.” Am J Psychiatry 151 (1994): 1546–56.

    Article  Google Scholar 

  18. M. Sabshin. “Report of the medical director.” Am J Psychiatry 148 (1991): 1444–50.

    Article  Google Scholar 

  19. M. Riba. “Presidential Address.” Am J Psychiatry 162 (2005): 2040–4.

    Article  Google Scholar 

  20. J. Borenstein. “The council on communications.” Am J Psychiatry 167 (2010): 228.

    Google Scholar 

  21. A cited by P. Breggin, Toxic Psychiatry (New York: St. Martin’s Press, 1991): 354.

    Google Scholar 

  22. G. Pollock. “Report of the treasurer.” Am J Psychiatry 138 (1981): 1415–17.

    Article  Google Scholar 

  23. F. Gottlieb. “Report of the speaker.” Am J Psychiatry 142 (1985): 1248.

    Article  Google Scholar 

  24. Psychiatric News, April 3, 1987; as cited by P. Breggin, Toxic Psychiatry (New York: St. Martin’s Press, 1991): 347.

    Google Scholar 

  25. E. Benedek. “Report of the secretary.” Am J Psychiatry 144 (1987): 1381–8; and Am J Psychiatry 145 (1988): 1328–36.

    Article  Google Scholar 

  26. M. Sabshin. “Report of the medical director.” Am J Psychiatry 145 (1988): 1340–2.

    Article  Google Scholar 

  27. N. Rao. “The council on medical education and career development.” Am J Psychiatry 158 (2001): 342–3;

    Google Scholar 

  28. J. Greden. “The council on research.” Am J Psychiatry 158 (2001): 346–8;

    Google Scholar 

  29. J. Scully. “Report of the medical director.” Am J Psychiatry 161 (2004): 1735–6.

    Google Scholar 

  30. C. Bernstein. “Report of the treasurer.” Am J Psychiatry 158 (2001): 1760–1. For percentages in 2006 and 2008, see APA report. “Pharmaceutical Revenue 2010,” which provided the amounts received from pharmaceutical companies from 2006 to 2010.

    Google Scholar 

  31. C. Bernstein. “Report of the treasurer.” Am J Psychiatry 159 (2002): 1622.

    Google Scholar 

  32. F. Gottlieb. “Report of the speaker.” Am J Psychiatry 142 (1985): 1246–9.

    Article  Google Scholar 

  33. M. Dumont. “In bed together at the market: psychiatry and the pharmaceutical industry.” Am J Orthopsychiatry 60 (1990): 484–5.

    Article  Google Scholar 

  34. E. Silverman. “Grassley probes psychiatrists over ties to pharma.” Pharmalot.comv, July 11, 2008.

    Google Scholar 

  35. A. Schatzberg, APA Presidential Address, Am J Psychiatry 167 (2010): 1161–5.

    Article  Google Scholar 

  36. L. Cosgrove. “Financial ties between DSM-IV panel members and the pharmaceutical industry.” Psychother Psychosom 75 (2006): 154–60.

    Article  Google Scholar 

  37. L. Cosgrove. “Conflicts of interest and disclosure in the American Psychiatric Association’s clinical practice guidelines.” Psychother Psychosom 78 (2009): 228–32.

    Article  Google Scholar 

  38. G. Fava. “Should the drug industry work with key opinion leaders? No.” BMJ 336 (2008): 1405.

    Article  Google Scholar 

Download references

Authors

Copyright information

© 2015 Robert Whitaker and Lisa Cosgrove

About this chapter

Cite this chapter

Whitaker, R., Cosgrove, L. (2015). Economies of Influence. In: Psychiatry Under the Influence. Palgrave Macmillan, New York. https://doi.org/10.1057/9781137516022_3

Download citation

Publish with us

Policies and ethics